Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

69.74
Delayed Data
As of Dec 09
 +2.15 / +3.18%
Today’s Change
66.93
Today|||52-Week Range
88.49
-18.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$162.1B

Company Description

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment supplies generic pharmaceuticals. The Corporate Activities segment includes other items of income and expense which are not attributable to specific segments such as certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations, and sponsorships. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Contact Information

Novartis AG
Lichtstrasse 35
Basel Basel-stadt (basle Town) 4056
P:(161) 324-1111
Investor Relations:
(161) 324-7944

Employees

Shareholders

Other institutional4.86%
Mutual fund holders4.02%
Individual stakeholders--

Top Executives

Joseph JimenezChief Executive Officer
Harry KirschChief Financial Officer
Vasant NarasimhanChief Medical Officer & Head-Drug Development
Shannon Thyme KlingerChief Ethics & Compliance Officer, Head-Litigation
Jürgen Brokatzky-GeigerGlobal Head-Corporate Responsibility